Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Study to Determine the Impact of Hemoglobin Maintenance and Other Interventional Strategies to Prevent or Delay the Progression of Left Ventricular Mass Growth in Subjects With Early Renal Insufficiency.

NCT00364260 is registered in ClinicalTrials.gov with Janssen-Ortho Inc., Canada as lead sponsor.

NCT NCT00364260
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00364260 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Study to Determine the Impact of Hemoglobin Maintenance and Other Interventional Strategies to Prevent or Delay the Progression of Left Ventricular Mass Growth in Subjects With Early Renal Insufficiency.
Lead sponsor
Janssen-Ortho Inc., Canada
Phase
Phase 3
Overall status
Completed
Start date
December 31, 1997
Completion date
August 31, 2003
Enrollment
172 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

anemia, kidney failure, left ventricular hypertrophy